Limiting Chemotherapy Side Effects by Using Moxa

Inclusion Criteria: * with breast, gynaecologic, or colorectal cancer who are prescribed radical or adjuvant chemotherapy in the early disease setting, or first or second line chemotherapy is in the metastatic setting * about to commence a course of chemotherapy for which granulocyte-colony stimulating factor (G-CSF) is not routinely indicated * with a life expectancy of more than six months * with blood cell counts within the normal range * with calculated creatinine levels of ≥ 50ml/min * English speaking * able to understand instructions for self-administration of moxibustion and carry out the procedure * able to give informed consent Exclusion Criteria: * having a haematological cancer diagnosis * prescribed a chemotherapy regimen for which G-CSF is indicated * having third or fourth line chemotherapy * having metastatic bone cancer * who have concomitant severe medical problems preventing participation * with cognitive impairment that would impact participant's ability to safely administer self-moxibustion * having renal dysfunction * with lymphedema in the lower body.